News

Tilray's distribution segment was the only one that generated double-digit growth in its most recent fiscal year.

Key Takeaways; Cannabis Sector Vireo Growth to Acquire Planet 13 in Landmark All-Stock Deal SNDL Completed Parallel Asset Acquisition, Expanding its U.S. Medical Cannabis Footprint Tilray Posted Record FY2026 Revenue as Cannabis Sales Rose and Losses Narrowed Key Takeaways; Psychedelic Sector Eli Lilly’s $3.8 Billion Deal to Acquire AtaiBeckley Signals a Major Push into Psychedelic-Inspired […]

Tilray Inc (NASDAQ:TLRY) is making progress in its transition into a diversified consumer products company, according to Jefferies, which reiterated its ‘Buy’ rating while lowering its price target to $19 from a higher prior target after cutting earnings forecasts. Shares traded up almost 3%...

Moby summary of Tilray Brands, Inc.'s Q4 2026 earnings call

Tilray Brands Inc (TLRY) reports significant financial improvements and outlines strategic plans for future expansion across diverse sectors.

Tilray Brands (NASDAQ:TLRY) reported record fiscal 2026 revenue and adjusted EBITDA, supported by growth in international cannabis, pharmaceutical distribution, wellness and the fourth-quarter acquisition of BrewDog. For the fiscal year ended May 31, 2026, net revenue rose 11% to $915.5 million fro

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $4.23, moving 1.63% from the previous trading session.

The president directed federal authorities to reschedule medical marijuana.

Village Farms has slid 27% in three months despite strong international cannabis growth. Can European expansion outweigh rising competition and pricing risks?

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $4.31, moving 1.6% from the previous trading session.

Key Takeaways; Cannabis Sector Tilray Brands Expanded Medical Cannabis Platform with HelloMD Acquisition Vireo Growth Entered Pennsylvania with $20 Million Retail License Deal Key Takeaways; Psychedelic Sector Optimi Health Shipped Third Commercial Psilocybin Export to Australia Helus Pharma Reported Wider Fiscal Year 2026 Loss as Lead Depression Drug Advances Toward Phase 3 Readout Clearmind Medicine […]

Tilray Brands, Inc. (NASDAQ:TLRY), backed by significant analyst-implied upside, ranks among the overlooked penny stocks to buy right now. A fresh acquisition aimed at deepening its medical cannabis footprint in Canada is giving investors a new angle on the stock despite a steep year-to-date selloff. On June 29, 2026, Tilray Brands, Inc. (NASDAQ:TLRY) announced the […]

There are much better ways to spend $5.

Tilray expands its medical cannabis strategy with HelloMD, adding virtual patient access as investors weigh growth potential against ongoing profitability challenges.

Taylor (pictured) was promoted from CFO to chief executive in March last year following the departure of James Arrow, who had been in the post for less than 12 months.

Cannabis investors have watched rescheduling euphoria ignite and incinerate capital at least four times since 2018, and a fresh DEA hearing is now on the calendar. The question is whether this cycle breaks the pattern or simply repeats it at a lower entry point.

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $4.46, denoting a -2.83% move from the preceding trading day.

The brand, said to "deliver clean, refreshing energy", is being sold online through Amazon and BrewDog's website.

In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $4.88, marking a -2.59% move from the previous day.

Investors seeking exposure to the marijuana market may now have a more attractive option to consider.

Key Takeaways; Cannabis Sector Aurora Cannabis Posted Record Medical Cannabis Revenue as International Growth Drove Fiscal 2026 Performance Trulieve Made History with NYSE Listing as CEO Sees New Era for U.S. Cannabis Tilray Medical Launched its First German-Grown Premium Cannabis Brand ARX Village Farms Expanded Dutch Production and Launched Pink Kush Vape in Canada Key […]

There are good things taking shape at Tilray, but there's one overriding theme that you can't ignore.

Tilray is launching 24 of its US craft beer SKUs through BrewDog's bars and website.

Tilray’s ARX brand will be launched at the world's largest cannabis expo and festival, Mary Jane Berlin 2026, which kicks off in two days.

Tilray Brands, Inc. (TLRY) closed at $5.03 in the latest trading session, marking a +1.82% move from the prior day.

Most of Tilray's sales come from Canada and the European Union.

Tilray bought Brewdog on the cheap, but there's a reason why it got such a good price.

Tilray Brands is back in focus as analysts reset their thinking on where the stock might be headed, with some firms cutting price targets in both US$ and C$ while others keep their fair value view anchored. Those target trims of about US$2 to US$3 per share and about C$3.50 are tied directly to mixed Street commentary that balances enthusiasm around cannabis rescheduling with caution on profitability and execution risks. Read on to see what these shifting targets could mean for you and how to...

Tilray stock was in focus after a recent government effort to reclassify Hemp and the upcoming DEA hearing about marijuana.

The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $5.38, representing a -2% change from its previous close.